Thromboxane A2 primarily promotes which process in heostasis?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Prepare for the NREMT Advanced-EMT Test. Use flashcards and multiple choice questions, complete with hints and explanations. Ready yourself for success on your exam!

Multiple Choice

Thromboxane A2 primarily promotes which process in heostasis?

Explanation:
Thromboxane A2 is a mediator released by activated platelets that amplifies the platelet response and helps form a hemostatic plug. It stimulates platelets to activate and aggregate, promoting the sticking together of platelets to seal a damaged vessel. It also causes vasoconstriction at the injury site to reduce blood flow and limit bleeding. Because of these actions, its primary effect is promoting platelet aggregation, not inhibiting it, causing vasodilation, or reducing coagulation factors.

Thromboxane A2 is a mediator released by activated platelets that amplifies the platelet response and helps form a hemostatic plug. It stimulates platelets to activate and aggregate, promoting the sticking together of platelets to seal a damaged vessel. It also causes vasoconstriction at the injury site to reduce blood flow and limit bleeding. Because of these actions, its primary effect is promoting platelet aggregation, not inhibiting it, causing vasodilation, or reducing coagulation factors.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy